C. Ryan Miller

Citée par

	Toutes	Depuis 2019
Citations	28458	13934
indice h	61	41
indice i10	114	90

3100

1550

775

2325

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202494 130 173 240 211 194 203 196 204 213 227 298 516 776 927 1300 1583 1953 2359 2357 2379 2729 3005 2647 2383 789

Accès public

Tout afficher

93 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Carey AndersProfessor of MedicineAdresse e-mail validée de duke.edu
Ralf S SchmidNovartis Institutes for BioMedical ResearchAdresse e-mail validée de novartis.com
Shawn HingtgenAssociate Professor, UNC Chapel Hill Eshelman School of PharmacyAdresse e-mail validée de email.unc.edu
G Yancey GillespieProfessor Emeritus of Neurosurgery, University of Alabama at BirminghamAdresse e-mail validée de uabmc.edu
D. Neil Hayes, MD, MPH, MSUniversity of Tennessee Health Science CenterAdresse e-mail validée de uthsc.edu
Joel ParkerUniversity of North Carolina at Chapel HillAdresse e-mail validée de email.unc.edu
Gary l JohnsonUniversity of North Carolina School of MedicineAdresse e-mail validée de med.unc.edu
Matthew D WilkersonAssociate Professor, Data Science Core Director, Uniformed Services UniversityAdresse e-mail validée de usuhs.edu
William ZamboniProfessor, University of North CarolinaAdresse e-mail validée de unc.edu
Juli R. BagoPrincipal Investigator at University of OstravaAdresse e-mail validée de osu.cz
Michael BerensProfessor, TGenAdresse e-mail validée de tgen.org
Jing WuNational Cancer Institute, National Institutes of HealthAdresse e-mail validée de nih.gov
Kenneth AldapeNational Cancer InstituteAdresse e-mail validée de nih.gov
Timothy GershonUniversity of North Carolina at Chapel HillAdresse e-mail validée de neurology.unc.edu
Harshil DhruvProteovant TherapeuticsAdresse e-mail validée de proteovant.com
Stephen FryeUNC Chapel HillAdresse e-mail validée de email.unc.edu
Steven AngusAssistant Professor, Indiana University School of Medicine, Department of PediatricsAdresse e-mail validée de iu.edu
Idoia GarciaIkerbasque Research Fellow, Biodonostia InstituteAdresse e-mail validée de biodonostia.org
Tal KafriAdresse e-mail validée de med.unc.edu
Daniel J BratDepartment of Pathology, Northwestern University Feinberg School of MedicineAdresse e-mail validée de northwestern.edu

Suivre

C. Ryan Miller

University of Alabama School of Medicine

Adresse e-mail validée de uab.edu - Page d'accueil

Glioma pathogenesis


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 RGW Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ... Cancer cell 17 (1), 98, 2010	7948	2010
The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013	4925	2013
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015	2886	2015
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016	1985	2016
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism I Dmitriev, V Krasnykh, CR Miller, M Wang, E Kashentseva, G Mikheeva, ... Journal of virology 72 (12), 9706-9713, 1998	956	1998
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor … CR Miller, DJ Buchsbaum, PN Reynolds, JT Douglas, GY Gillespie, ... Cancer research 58 (24), 5738-5748, 1998	461	1998
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob V Krasnykh, I Dmitriev, G Mikheeva, CR Miller, N Belousova, DT Curiel Journal of virology 72 (3), 1844-1852, 1998	460	1998
An animal model of MYC-driven medulloblastoma Y Pei, CE Moore, J Wang, AK Tewari, A Eroshkin, YJ Cho, H Witt, ... Cancer cell 21 (2), 155-167, 2012	377	2012
Glioblastoma CR Miller, A Perry	318	2009
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types MD Wilkerson, X Yin, KA Hoadley, Y Liu, MC Hayward, CR Cabanski, ... Clinical cancer research 16 (19), 4864-4875, 2010	308	2010
ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma SA Brooks, AR Brannon, JS Parker, JC Fisher, O Sen, MW Kattan, ... European urology 66 (1), 77-84, 2014	276	2014
Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation MD Wilkerson, X Yin, V Walter, N Zhao, CR Cabanski, MC Hayward, ... PloS one 7 (5), e36530, 2012	260	2012
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class WC Rutledge, J Kong, J Gao, DA Gutman, LAD Cooper, C Appin, Y Park, ... Clinical Cancer Research 19 (18), 4951-4960, 2013	205	2013
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases A Perry, CR Miller, M Gujrati, BW Scheithauer, SC Zambrano, SC Jost, ... Brain Pathology 19 (1), 81-90, 2008	198	2008
Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas CR Miller, CP Dunham, BW Scheithauer, A Perry Journal of clinical oncology 24 (34), 5419-5426, 2006	191	2006
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy L Yuan, M Siegel, K Choi, C Khosla, CR Miller, EN Jackson, ... Oncogene 26 (18), 2563-2573, 2007	190	2007
A system for the propagation of adenoviral vectors with genetically modified receptor specificities JT Douglas, CR Miller, M Kim, I Dmitriev, G Mikheeva, V Krasnykh, ... Nature biotechnology 17 (5), 470-475, 1999	189	1999
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases CK Anders, AM Deal, CR Miller, C Khorram, H Meng, E Burrows, C Livasy, ... Cancer 117 (8), 1602-1611, 2011	177	2011
HIF1α and HIF2α independently activate SRC to promote melanoma metastases SC Hanna, B Krishnan, ST Bailey, SJ Moschos, PF Kuan, T Shimamura, ... The Journal of clinical investigation 123 (5), 2078-2093, 2013	168	2013
Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas CR Miller, CR Williams, DJ Buchsbaum, GY Gillespie Cancer research 62 (3), 773-780, 2002	157	2002

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs